![Cognition Therapeutics Inc](/common/images/company/N_CGTX.png)
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate, CT1812, is an o... Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate, CT1812, is an orally delivered, small molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.52 | 76.7676767677 | 1.98 | 2.535 | 1.709 | 279153 | 1.93041695 | CS |
4 | 1.82 | 108.333333333 | 1.68 | 2.535 | 1.65 | 179479 | 1.89648116 | CS |
12 | 1.55 | 79.4871794872 | 1.95 | 2.95 | 1.61 | 164594 | 2.02086518 | CS |
26 | 1.1 | 45.8333333333 | 2.4 | 2.95 | 1.61 | 179273 | 1.99409955 | CS |
52 | 1.79 | 104.678362573 | 1.71 | 2.95 | 0.9001 | 154141 | 1.84457557 | CS |
156 | -8.65 | -71.1934156379 | 12.15 | 13.8 | 0.9001 | 164105 | 2.99992538 | CS |
260 | -8.65 | -71.1934156379 | 12.15 | 13.8 | 0.9001 | 164105 | 2.99992538 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.